Anthony G. Quinn
2019
In 2019, Anthony G. Quinn earned a total compensation of $2.5M as Chief Executive Officer at Aeglea BioTherapeutics, a 35% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $247,000 |
|---|---|
| Salary | $518,000 |
| Stock Awards | $1,663,919 |
| Other | $53,857 |
| Total | $2,482,776 |
Quinn received $1.7M in stock awards, accounting for 67% of the total pay in 2019.
Quinn also received $247K in non-equity incentive plan, $518K in salary and $53.9K in other compensation.
Rankings
In 2019, Anthony G. Quinn's compensation ranked 4,888th out of 13,971 executives tracked by ExecPay. In other words, Quinn earned more than 65.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,888 out of 13,971 | 65th |
Division Manufacturing | 1,823 out of 5,695 | 68th |
Major group Chemicals And Allied Products | 634 out of 2,194 | 71st |
Industry group Drugs | 534 out of 1,880 | 72nd |
Industry Pharmaceutical Preparations | 399 out of 1,392 | 71st |
Source: SEC filing on April 23, 2020.
Quinn's colleagues
We found two more compensation records of executives who worked with Anthony G. Quinn at Aeglea BioTherapeutics in 2019.
News
Aeglea BioTherapeutics CEO Anthony Quinn's 2022 pay slips 9% to $2.4M
April 17, 2023
Aeglea BioTherapeutics CEO Anthony Quinn's 2021 pay slips 10% to $2.6M
April 21, 2022
Aeglea BioTherapeutics CEO Anthony Quinn's 2019 pay falls 35% to $2.5M
April 23, 2020
Aeglea BioTherapeutics CEO Anthony Quinn's 2018 pay jumps 274% to $3.8M
April 22, 2019